Antoni Hurtado

4PUBLICATIONS
4CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 28, 2025
HapA protease targets PAR-1/2 to modulate ERK signalling and reduce cancer cell viability.

David Tena-Chaves, Inês Pontes-Gomes, José Ángel Palomeque

|Feb 05, 2022
Targeting CDK4/6 reorganizes chromatin.

Antoni Hurtado

Pageof 1